Creation principles, mechanism of action and clinical application of probiotics (review)
Keywords:
bacteriemic preparations, probiotics, dysbacteriosis, gen-modified strains, Subalinum, Bacillus, probiotic therapy.Abstract
In the presented review the general data concerning probiotics is considered, i.e. definitions of the term, classification principles, and the core benefits of usage if compared to antibiotics. Are noted The criteria of choice and the characteristics of the main sorts of bacteria used as basic probiotics. Special attention in terms of usage for producing bacteriemic medicines is paid to Bacillus spore-former bacteria, as normal micro-flora exogenous components that do not produce biofilms. Bacillus sporeformer bacteria are also able to produce a wide spectrum of biologically active substances, including antibiotics, lysozyme, proteolytic enzymes, and able to influence the immunological reactivity of macro-organism, therefore stimulating the growth of secretory immunoglobulins`, macrophages`, natural killers` activity. The Subalinum biological features are considered. The basic for Subalinum is genetically modified strain of Bacillus subtillis 2335/105 with a plasmid, containing the gene for alpha-2 human interferon. The characteristics for genetically modified strains of E. coli is given, as being perspective for creating probiotics for effective treatment of diarrhea, caused by enterotoxigenic E.coli and Vibrio cholera. They are proposed for creating recombinant strains of bifidobacteria for atherosclerosis and cardiovascular diseases` treatment and prevention. They are also prospective for making Lactococcus lactis recombinative strain for ulcerative colitis and Crohn's diseases` treatment. The potential dangers of drugs based on living organisms are being discussed. Some of the mechanisms of probiotics influence on the immune system and aspects of clinical application of probiotics for preventing and treating dysbiosis, atopy, intestinal infections of bacterial and viral, cardiovascular, cancer and secondary immunodeficiencies, are highlighted. The research paper contains the possibility of co-using probiotics as vaccination adjuvant.
References
Lee, W. Obesity in the United States – dysbiosis from exposure to low-dose antibiotics [Electronic resource] / W.Lee, I. Riley, E.Raphael, E. Faerstein2 // Epidemiology. – 2013.– V.1. – P. 69-71. – Access : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867737/ Brown, K. Diet-Induced Dysbiosis of the Intestinal Microbiota and the Effects on Immunity and Disease [Electronic resource] / K.Brown, D.DeCoffe, E.Molcan, D.L.Gibson // Nutrients.– 2012.– V. 4(8). – P.1095–1119. – Access : http://www.ncbi.nlm.nih.gov/pubmed/23016134
Galland, L. Intestinal Dysbiosis and the Causes of Disease [Electronic resource] / L. Galland, S. Barrie [Electronic resource] // Access : http://www.healthy.net/Health/Article/Intestinal_Dysbiosis_and_the_Causes_of_Disease/423
Costello, E. Bacterial community variation in human body habitats across space and time [Electronic resource] / E. Costello, C. Lauber, M. Hamady, N. Fierer, J. Gordon, R. Knight // Science. – 2009. – V. 326. – P. 1694-1697. – Access : http://www.ncbi.nlm.nih.gov/pubmed/19892944
Turnbaugh, P. The core gut microbiome, energy balance and obesity [Electronic resource] / P.Turnbaugh, J. Gordon.// J. Physiol. – 2009. – V.587. – P.4153 4158. – Access : http://jp.physoc.org/content/587/17/4153.full
Rescigno, M. The intestinal epithelial barrier in the control of homeostasis and immunity [Electronic resource] / M Rescigno // Trends in Immunology. – 2011. – V.32. – P. 256-264. – Access : http://www.ncbi.nlm.nih.gov/pubmed/21565554
Sjogren, Y. M. Influence of early gut microbiota on the maturation of childhood mucosal and systemic immune responses [Electronic resource] / Y. M. Sjogren // Clinical Experimental Allergy.– 2009.– V.39. – P. 1842-1851. – Access : http://www.ncbi.nlm.nih.gov/pubmed/19735274
Serino, M. Intestinal microflora and metabolic diseases. [Electronic resource] / M.Serino, E. Luche, C.Chabo, J.Amar, R. Burcelin // J.Diabetes Metab. – 2009. – V.35. – P.262–272. – Access : http://www.ncbi.nlm.nih.gov/pubmed/19419895
Saputo L. Practical Clinical Guide to Understanding Dysbiosis and Irritable Bowel Syndrome [Electronic resource] // by L. Saputo // Access : http://www.doctorsaputo.com/a/a-practical-clinical-guide-to-understanding-dysbiosis-and-irritable-bowel-syndrome-ibs
Uspenskiy, Ju.P. Prospects for the use of multi-view of probiotics for the prevention of antibiotic-associated diarrhea [Text] / Y.P. Uspenskiy, S.M. Zakharenko, Y.A.Fominych // Experimental and clinical gastroenterology.– 2013. – V.2. – P. 54-64.
Caramia, G. Probiotics: from Metchnikoff to the current preventive and therapeutic possibilities [Electronic resource] / G. Caramia // Pediatr. Med. Chir. – 2004. – V. 26 (1). – P. 19–33. – Access : http://www.ncbi.nlm.nih.gov/pubmed/15529809
Lilly, D. M. Probiotics: Growth promoting factors produced by microorganisms [Text] / D.M. Lilly, R. H. Stillwell // Science. – 1965. – Vol. 147. – P. 747–748.
Shenderov, B. A. Medical microbial ecology and functional food [Text] / B.A.Shenderov // M. : Grant, 1998.– 288 p.
Shenderov, B. A. Metabiotics: novel idea or natural development of probiotic conception [Electronic resource] / B.A. Shenderov // Microb Ecol Health Dis.– 2013. – V. 24. – P. 1–8. – Access : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747726/pdf/MEHD-24-20399.pdf
Kneifel, W. Probiotics and Health Claims [Text] / W. Kneifel, S.Salminen // Wiley-Blackwell, 2011. — 360 p.
Yakovenko, E. P Innovative multi species and multi strains probiotics in clinical practice [Electronic resource] / E. P. Yakovenko [et al] // Attending physician. – 2014. – N5. – Access : http://www.lvrach.ru/2014/05/15435967/
Timmerman, H.M.Monostrain, multistrain and multispecies probiotics. Acomparison of functionality and efficacy [Electronic resource] / H.M.Timmerman, C.J.M.Koning, L. Mulder, F.M. Rombouts, A.C. Beynen // International Journal of Food Microbiology. –2004. – V. 96 (3). P. 219-233. – Access : http://www.ncbi.nlm.nih.gov/pubmed/15454313
Taibi, A. Practical approaches to probiotics use [Electronic resource] / A. Taibi, E.M. Comelli //Appl. Physiol. Nutr. Metab.– 2014. – V. 39 (8). – P. 980-986. – Access : http://www.ncbi.nlm.nih.gov/pubmed/24797031
Dinleyici, E.C.The effect of a multispecies synbiotic mixture on the duration of diarrhea and length of hospital stay in children with acute diarrhea in Turkey: single blinded randomized study [Text] / E.C.Dinleyici [et al.] // Eur. J. Pediatr. – 2013. – V. 172 (4). – P. 459-464.
Vitetta, L. Probiotics, prebiotics and the gastrointestinal tract in health and disease [Electronic resource] / L.Vitetta, D.Briskey, H.Alford, S.Hall, S.Coulson // Inflammopharmacology. – 2014. – V. 22(3). – P.135-154. – Access : http://www.ncbi.nlm.nih.gov/pubmed/24633989
Chralampopoulos, D. Prebotics and Probiotics Science and Technology [Text] / D.Chralampopoulos, R. A. Rastall // — UK: Springer, 2009. — 1265 p.
Serebryakova, E.N. Probiotics for Prevention and Treatment at Diarrhea in Children [Electronic resource] / E.N. Serebryakova // The difficult patient. – 2014. – V.12. – N5. – P.20-25. – Access : http://t-pacient.ru/wp-content/uploads/2014/06/TP-5-2014.pdf
Ashraf, R. Immune system stimulation by probiotic microorganisms [Electronic resource] / R. Ashraf, N.P. Shah // Crit. Rev. Food Sci. Nutr. – 2014. – V.54 (7). – P. 938-956. – Access : http://www.ncbi.nlm.nih.gov/pubmed/24499072
Dattilio, A. M. Probiotics in pediatrics: a review of concepts, mechanisms, and benefits [Text] / A. M.Dattilio, J. M. Saavedra // Clinical nutrition highlights. – 2009. – V. 5. – P. 2–8.
Bondarenko, V. M. Molecular cellular mechanisms of therapeutic action of probiotic drugs [Electronic resource] /V. M. Bondarenko// J. Farmateka. – 2010. – V. 196. – N2. – P. 26–32. – Access : http://www.pharmateca.ru/en/archive/article/7714
Subalinum. A fundamentally new approach to the treatment of bacterial and viral infections [Text] / I. B. Sorokulova [et al] // K., 2010. – 36p.
Koutelidakis, I. M. Impact of synbiotics on the intestinal flora of critically ill patients with multiple injuries [Electronic resource] / I.M.Koutelidakis [et al] // Int. J. Antimicrob. Agents. – 2010. – V. 36. – P. 90–91. – Access : http://www.ncbi.nlm.nih.gov/pubmed/20346633
Andi, L. Guide to designing, conducting, publishing and communicating results of clinical studies involving probiotic applications in human participants [Electronic resource] / L Andi. [et al] // Gut Microbes. – 2010. – V. 1(4). – P. 243-253. – Access : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023606/
Dekker, J. Probiotics revisited: new strains, new benefits, new opportunities [Text] / J. Dekker; S. Ukraintsev // Pediatric Pharmacology. – 2012. –V.9 (2) – P.40-45.
Dekker, J. W. Safety aspects of probiotic bacterial strains Lactobacillus rhamnosus HN001 and Bifidobacterium animalis subsp. lactis HN019 in human infants aged 0-2 years [Text] / J. W. Dekker [et al.]. // International Dairy Journal. – 2009. – V.19. – P. 149-154.
Turroni, F. Microbiomic analysis of the bifidobacterial population in the human distal gut [Electronic resource] / F. Turroni [et al.] // ISME J. – 2009. – V. 3. – P. 745-751. – Access : http://www.ncbi.nlm.nih.gov/pubmed/19295640
Starovoitova, S.A. Search of strains of bacteria Lactobacillus and Bifidobacterium of genus perspective for creation of probiotics [Text] / S.A. Starovoitova [el al.] // Sci. Bull. Uzhgorod Univ. (Ser. Biol.) – 2009. – V. 26. – P. 216-219.
Anderson, R. C. Lactobacillus plantarum DSM 2648 is a potential probiotic that enhances intestinal barrier function [Text] / R. C. Anderson [et al.] // FEMS Microbiology Letters. – 2010. – V.309. – P. 184-192.
Pat. 92983 UA, 5 МПК d2N1/20, C12R1/225, А61Р37/02. Strain Lactobacillus delbrueckii subsp. bulgaricus ІМВ-В-7281 – activator of phagocites [Electronic resource] / Spivak M., Pidhorskyy V., Shynkarenko L., Lazarenko L., Timoshok N., Gorchakov V., Starovoitova S.; applicant Danylo Zabolotny Institute of Microbiology National Academy of Science of Ukraine. – № a 200907302 ; stated 13.07.2009 ; published 11.10.2010. Bull. № 19., 2010. – Access : http://dspace.nuft.edu.ua/jspui/handle/123456789/10976
Tanabe, S. Bifidobacterium infantis suppresses proinflammatory interleukin-17 production in murine splenocytes and dextrain sodium sulfate-induced intestinal inflammation [Electronic resource] / S.Tanabe, Y. Kinuta, Y. Saito // Int J Mol Med.– 2008. – V. 22 (2). – P. 181-185.– Access : http://www.ncbi.nlm.nih.gov/pubmed/18636171
Tuohy, K.M. The way to a man’s heart is through his gut microbiota’ – dietary pro- and prebiotics for the management of cardiovascular risk [Electronic resource] / K.M. Tuohy, F.Fava, R. Viola //Proc Nutr Soc. – 2014. – V. 4. – P. 1–14. – Access : http://www.ncbi.nlm.nih.gov/pubmed/24495527
Nishitani, Y. Lactococcus lactis subsp. cremoris FC alleviates symptoms of colitis induced by dextran sulfate sodium in mice. [Electronic resource] / Y. Nishitani [et al.] // Int Immunopharmacol. – 2009. – V.9. – P. 1444-1451. – Access : http://www.ncbi.nlm.nih.gov/pubmed/19733697
Li, C.Y. Immunomodulatory effects of lactobacillus and Bifidobacterium on both murine and human mitogen-activated T cells. [Electronic resource ] / C.Y. Li, H.C.Lin, C.H.Lai, J.J. Lu, S.F. Wu, S.H. Fang // Int Arch Allergy Immunol. – 2011. – V.156 (2). – P. 128–136.- Access : http://www.ncbi.nlm.nih.gov/pubmed/21576983
Shevyakov, M.A. / Immunomodulation by using probiotics: range of clinical applications and conditions for effectiveness [Electronic resource] / M.A. Shevyakov, A.V. Sobolev // The difficult patient. – 2013. – V. 11. – №11. – 43-47. – Access : http://t-pacient.ru/articles/8080/
Kikuchi, Y. Oral Administration of Lactobacillus plantarum Strain AYA Enhances IgA Secretion and Provides Survival Protection against Influenza Virus Infection in Mice [Electronic resource] / Y. Kikuchi [et al.] // PLoS ONE. – 2014. – V. 9 (1). – Access : http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0086416
Berlec, A. Novel applications of recombinant lactic acid bacteria in therapy and in metabolic engineering [Electronic resource] / A.Berlec, B.Struketj // Rec. Patents Biotechnol. — 2009. — V. 3. — P. 77-87.– Access : http://www.ncbi.nlm.nih.gov/pubmed/19519564
Tuomola, E. M. Adhesion of some probiotic and dairy Lactobacillus strains to Caco-2 cell cultures [Electronic resource] / Tuomola EM, Salminen SJ. // Int J Food Microbiol May. – 1998. – V. 41(1). – P. 45-51. – Access : http://www.ncbi.nlm.nih.gov/pubmed/9631336
Tuomola, E. M. Chemical, physical and enzymatic pre-treatments of probiotic lactobacilli alter their adhesion to human intestinal mucus glycoproteins [Electronic resource] / E.M. Tuomola, A.C. Ouwehand, S.J. Salminen // Int. J. Food Microbiol. – 2000. – V. 60(1). – P. 75-81. – Access : http://www.ncbi.nlm.nih.gov/pubmed/11014524
Pat. 2144954 The Russian Federation, МПК C12N1/21, A61K35/74. The bacterial strain of Escherichia coli M 17/pColap used to obtain probiotic preparation [Electronic resource] / Livshits V.A., Chesnokova V.L., Aleshin V.V., Sokurenko E.V., Dalin M.V., Kravtsov E.G., Bykov V.A. – States 15.04.1998 ; published 27.01.2000. - Access : http://bd.patent.su/2225000-2225999/pat/servl/servlet9cce.html
Arribas, B. A probiotic strain of Escherichia coli, Nissle 1917, given orally exerts local and systemic anti-inflammatory effects in lipopolysaccharide –nduced sepsis in mice [Electronic resource] / B. Arribas [et al.] // Br J Pharmacol. – 2009. – V. 157. – P. 1024 - 1033. – Access : http://www.ncbi.nlm.nih.gov/pubmed/19486007
Zakharenko, S. M. Conception of doctors about modern probiotics [Text] / S. M. Zakharenko // Consilium medicum. – 2011. – Т.13, №7. – С.60-65.
Selvam, R. Effect of Bacillus subtilis PB6, a natural probiotic on colon mucosal inflammation and plasma cytokines levels in inflammatory bowel disease [Electronic resource] / R. Selvam, P. Maheswari, P. Kavitha, M. Ravichandran, B. Sas, C. Ramchand // Indian J Biochem Biophys. – 2009. – V. 46. – P. 79-85. - Access : http://www.ncbi.nlm.nih.gov/pubmed/19374258
Pat. 2159625 The Russian Federation 5 МПК A61K35/66. Probiotic preparation of a comprehensive action [Text] / Belyavskaya V.A., Kashperova T.A., Sorokulova I.B., Smirnov V.V., Ilichev A.A., Panin A.N., Malik N.I., Sandakhchiev L.S.; applicant State Research Center of Virology and Biotechnology Vector ; appl. 99111728/14, 25.05.1999; published 27.11.2000.
Sorokulova, I. B. Preclinical testing in the development of probiotics: a regulatory perspective with Bacillus strains as an example [Text] / I. B. Sorokulova // Clinical Infectious Diseases. – 2008. – V.46. – P. S92–S96.
Grinko, O. M. Isolation and study of perspective probiotic strain of spore-forming bacteria from Bacillus genus [Text] / O.M. Grinko, V.V. Zverev, A.A. Kaloshin, N.A. Mikhaylova, V.G. Arzumanyan // Zh. Mikrobiol. (Moscow). – 2009. V. 3. – P. 85—89.
Legeza, K. N. Application of Biosporinum during the treatment of intestinal infections [Text] / K.N. Legeza, V.Y. Chaplinskyi, I.B. Sorokulova, S.V. Yakimova, D. M. Gritsaenko // Contemporary Pediatrics.– 2013. – V. 5 (53). – P. 172-174.
Starovoitova, S. А. Probiotic is based on transgenic microorganism [Text] / S. А. Starovoitova, O. I.. Skrotska // Biotechnologia Acta. – 2013.– V. 1. – P. 34-45.
Icy, D’Silva. Recombinant technology and probiotics [Electronic resource] / D’Silva Icy // International Journal of Engineering and Technology. – 2011. – Vol.3. – P. 288–293.– Access : http://www.enggjournals.com/ijet/docs/IJET11-03-04-25.pdf
Skrotska, O. Use of recombinant microorganisms for creation of modern probiotic preparations [Text] // O.Skrotska, S. Starovoitova, Yu.Penchuk, Ya.Gavrish // Scientific papers NUFT. – 2012. – V.42. – P. 41-46.
Belyavskaya, V. A. Prospects for constructing immune preparations based on recombinant bacilli [Text] / V.A. Belyavskaya, I.B. Soroculova, A.A. Iljchev // Intern.J.Immunorehabilitation.– 1994. – V. 1. - P.56.
Pat. 2035185 The Russian Federation 5 МПК A61K35/66ю Preventive biological preparation of subalinum [Text] / Smirnov V.V.; Reznik S.R.; Sorokulova I.B., Sandakhchiev P.S., Petrenko V.A., Ilichev A.A., Belyavskaya V.A Timofeev I.V. ; applicant Danylo Zabolotny Institute of Microbiology National Academy of Science of Ukraine and State Research Center of Virology and Biotechnology Vector; appl. 5025233/13, 31/01/1992 ; published 20.05.1995.
Round, J. L. The toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota [Electronic resource] / J. L. Round [et al.] // Science.– 2011.– V. 332. – P. 974–977. – Access : http://www.ncbi.nlm.nih.gov/pubmed/21512004
Herberth, G. Reduced IFN-y- and enhanced IL-4-producing CD4+ cord blood T cells are associated with a higher risk for atopic dermatitis during the first 2 yr of life. Pediatric [Electronic resource] / G. Herberth [et al.] // Allergy Immunology. – 2010. – V. 21. – P. 5-13. – Access : http://onlinelibrary.wiley.com/doi/10.1111/j.1399-3038.2009.00890.x/abstract
Wang, M. Microbial hijacking of complement-toll-like receptor crosstalk [Electronic resource] / M.Wang [et al.] // Sci. Signal. – 2010. – V.3. – P.11.– Access : http://www.ncbi.nlm.nih.gov/pubmed/20159852
Focareta, A. Recombinant Probiotic for Treatment and Prevention of Cholera [Electronic resource] / A. Focareta [et al.] // Ibid. — 2006. — V. 130. — P. 1688-1695. – Access : http://www.ncbi.nlm.nih.gov/pubmed/16697733
Paton, A. W. Recombinant Probiotics for Treatment and Prevention of Enterotoxigenic Escherichia coli Diarrhea [Electronic resource] / A. W. Paton [et al.] // Gastroenterology. — 2005. — V. 128. — P. 1219-1228. – Access : http://www.ncbi.nlm.nih.gov/pubmed/15887106
Remaut, E. Clinical potential of Lactococcus lactis mediated delivery of human interleukin-10 and trefoil factors [Text] / E. Remaut [et al.] // Biosci. Microflora. — 2006. — V. 25. — P. 81-97.
Llopis, M. Lactobacillus casei downregulates commensals’ inflammatory signals in Crohn’s disease mucosa [Electronic resource] / M. Llopis [et al.] // Inflamm. Bowel Dis. – 2009. – V.15. – P. 275 283. – Access : http://www.ncbi.nlm.nih.gov/pubmed/18839424
Cannon, J. P. Pathogenic relevance of Lactobacillus: A Retrospective review of over 200 cases. [Electronic resource] / J. P. Cannon, T.A. Lee, J.T. Bolanos, L.H. Danziger // European Journal of Clinical Microbiology. – 2005. – V. 24 (1). – P. 31-40. – Access : http://www.ncbi.nlm.nih.gov/pubmed/15599646
Domann, E. Culture-independent identification of pathogenic bacteria and polymicrobial infections in the genitourinary tract of renal transplant recipients [Electronic resource] / E. Domann [et al.] // Journal of Clinical Microbiology. – 2004. – V. 41(12). – P. 5500-5510. – Access : http://www.ncbi.nlm.nih.gov/pubmed/14662931
Schmaldienst, S. Urinary Tract Infections After renal transplantation [Electronic resource] / S. Schmaldienst, E. Dittrich, W. H. Hörl // Current opinion in urology. – 2002. – V.12 (2). – P. 125-130. – Access : http://www.ncbi.nlm.nih.gov/pubmed/11859258
Chazan, B. Bacteremia and pyelonephritis Caused by Lactobacillus jensenii in A Patient with urolithiasis [Electronic resource] / B. Chazan, R. Raz, Y.Shental, H. Sprecher, R. Colodner // The Israel Medical Association journal: IMAJ. – 2008. – V.10 (2). P. 164-165. – Access : http://www.ncbi.nlm.nih.gov/pubmed/18432039
Duprey, K. M. Pyelonephritis and bacteremia from Lactobacillus delbrueckii [Electronic resource] / K. M. Duprey, L.McCrea, B.L. Rabinowitch, K. N. Azad // Case reports in infectious diseases. – 2012. – P. 743 -745. – Access : http://www.ncbi.nlm.nih.gov/pubmed/23056967
Suárez-García I. Lactobacillus bacteremia and endocarditis jensenii dilatation and curettage After: Case report and Literature review [Electronic resource] / I. Suárez-García, A. Sánchez-García, L. Soler, E. Malmierca, J. Gómez-Cerezo // Infection. – 2011. – V. 40 (2). – P. 219-222. – Access : http://www.ncbi.nlm.nih.gov/pubmed/21866337
Rostagno, C. Early Lactococcus lactis endocarditis after mitral valve repair: a case report and literature review [Electronic resource] / C. Rostagno, P. Pecile, P.L. Stefàno // Infection . – 2013. – V. 41. – P. 897-899. – Access : http://www.ncbi.nlm.nih.gov/pubmed/23225172
Rasmussen, M. Lactococcus garvieae endocarditis presenting with subdural haematoma [Electronic resource] / M. Rasmussen, J. B. Werner, M. Dolk, B. Christensson // BMC Cardiovascular Disorders .– 2014. – V. 14(1).– P.13. – Access : http://www.biomedcentral.com/1471-2261/14/13
Lee, J.Y. Polymicrobial Peritonitis with Lactococcus lactis in a Peritoneal Dialysis Patient [Electronic resource] / J. Y. Lee [et al.] // Chonnam Medical Journal. – 2014. – V. 50(2). – P. 67-69. – Access : http://www.ncbi.nlm.nih.gov/pubmed/25229019
Rolph, H. J. Molecular identification of microorganisms from endodontic infections [Electronic resource] / H.J. Rolph [et al.] //J Clin Microbiol. – 2001. – V. 39(9). – P. :3282-3289. – Access : http://www.ncbi.nlm.nih.gov/pubmed/11526164
Hong, B.Y. Microbial analysis in primary and persistent endodontic infections by using pyrosequencing [Electronic resource] / B.Y.Hong [et al. ] // J Endod.– 2013. – V. 39(9). – P. 1136-1140. – Access : http://www.ncbi.nlm.nih.gov/pubmed/23953286
Avlami, A. Lactobabacillus rhamnosus endocarditis complicating coloscopy [Text] / A. Avlami, T. Kordossis, N. Vrizidis, N.V. Sipsas. // J.Infect. – 2001. – V. 42(4). – P.283-285.
Farina, C, Arosio M, Mangia M, Moioli F. Lactobacillus casei subsp. rhamnosus sepsis in a patient with ulcerative colitis [Electronic resource] / C. Farina, M. Arosio, M. Mangia, F. Moioli //J Clin Gastroenterol. – 2001. – V. 33(3). – P. 251-252. – Access : http://www.ncbi.nlm.nih.gov/pubmed/11500620
Jones, R. Lactobacillus allograft pyelonephritis and bacteremia [Electronic resource] / R.Jones, M. Ellbogen, R.Dunlay // Nephron. – 2001. – V. 86(4). – P. 502. – Access : http://www.ncbi.nlm.nih.gov/pubmed/11124601
Peters, L. B. Combinations of bacterial species in endodontic infections [Electronic resource] / L.B. Peters, P.R. Wesselink, A.J. van Winkelhoff // Int Endod J.– 2002. – V. 35(8). – P. 698-702. – Access :http://www.ncbi.nlm.nih.gov/pubmed/12196223
Berg, R.D. Bacterial translocation from the intestines [Electronic resource] / R.D. Berg. // Adv Exp Med Biol.– 1999. – V.473. – P.11-30. – Access : http://www.ncbi.nlm.nih.gov/pubmed/10659341
Subbotin, V.V. Probiotics for the prevention and elimination of dysbacterioses: rational choice of drugs [Electronic resource ] / V.V. Subbotin, N.V. Danilevskaya // JSAP. – 2012. –V.3. – №3. – P. 56-57. – Access : http://cyberleninka.ru/article/n/o-nekotoryh-posledstviyah-dlitelnoy-antibakterialnoy-terapii-1
Danilevskaya, N.V. About some consequences of prolonged antibiotic therapy [Text] / N.V. Danilevskaya, V.V. Subbotin // JSAP Russian edition. – 2012.– V.3. – P. 56-57.
Lebedev, K.A. Immunology of pattern recognition receptors (integrated immunology) [Text] / . K.A. Lebedev, I.D. Ponyakina.// M. : publishing house "Librokom", 2009. – 256 p.
Mazankova, L.N. Probiotics and the immune system (the concept of biologic therapy) [Text] / L.N. Mazankova, Chebotareva T.A., Maikova I.D. // Consilium medicum. –— 2007. — P. 16-19.
Prisciandaro, L. Probiotics and their derivatives as treatments for inflammatory bowel disease [Electronic resource] / L. Prisciandaro, M. Geier, R. Butler, A.Cummins, G. Howarth // Inflamm Bowel Dis. – 2009. – V.15. – P. 1906-1914. – Access : http://www.ncbi.nlm.nih.gov/pubmed/19373788
Boyle, R. J. Probiotics for the treatment of eczema: a systematic review [Electronic resource] / R Boyle [et al.] // Clinical Experimental Allergy. – 2009. –V. 39. – P. 1117-1127. – Access : http://www.ncbi.nlm.nih.gov/pubmed/19573037
Khromova, S. C., Saparov A.N. Intestinal microflora and mechanisms of immunoregulation. [Electronic resource] / S. C. Khromova, A.N. Saparov // Issues of child nutrition.- 2005. – V. 1(3).– Pp.92-96. – Access : http://gastroportal.ru/php/content.php?id=1707
Verdu, E.F. Irritable Bowel Syndrome and Probiotics: From Rationale to Clinical Use [Text] / E.F. Verdu, S.M. Collins // Curr Opin Gastroenterol. – 2005/ – V. 21(6). – P. 697–701.
Potebnya, G.P. Subalin probiotic preparation increases the efficiensy of cancer vaccine [Text] / G.P. Potebnya [et al.] // Oncologi. – 2008. – V.10 (2). – P.246-251.UDK 579.61 : 579.255 : 579.852.1 : 615.33.1
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2020 Annals of Mechnikov's Institute
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 Unported License.
